Amicus Therapeutics(FOLD) - 2023 Q2 - Earnings Call Transcript

Amicus Therapeutics Inc. (NASDAQ:FOLD) Q2 2023 Results Conference Call August 8, 2023 8:30 AM ET Company Participants Andrew Faughnan - Vice President, Investor Relations Bradley Campbell - President, Chief Executive Officer Daphne Quimi - Chief Financial Officer Sébastien Martel - Chief Business Officer Jeff Castelli - Chief Development Officer Mitchell Goldman - Chief Medical Officer Ellen Rosenberg - Chief Legal Officer Conference Call Participants Tazeen Ahmad - Bank of America Anupam Rama - JPMorgan Ri ...